(Telestock) – Bayera German company and one of the world’s leading multinational pharmaceutical companies, is trading on the Frankfurt Stock Exchange, where it is by far the largest best DAX stock. The purchases of the title were driven by a Legal victory in the United States in one of the many proceedings involving his controversial herbicide Roundup.
In particular, a U.S. appeals court said that federal law shields Bayer from a lawsuit brought by a landscaper Pennsylvaniaaccording to which Monsanto (in the meantime acquired by Bayer) would have violated the state law by not placing acancer warning on label of Roundup. The court said the Federal Insecticide, Fungicide, and Rodenticide Act requires nationwide uniformity in pesticide labels and prevented Pennsylvania from adding a cancer warning.
This sentence is in conflict with others of the federal appeals courts in San Francisco and Atlanta. This could lead to the Supreme Court of the United States to intervene to resolve the dispute.
Bayer reiterated that Roundup and its active ingredient, glyphosate, are safe and said it “continues to fully support” the brand, despite the numerous lawsuits that it has faced since it acquired Monsanto in 2018 for $63 billion.
Excellent performance of BayerThat stands at 29.19 euroswith a increase of 11.09%. At the operational level, a continuation of the session is expected under the sign of the bull with resistance seen at 30.22 and then at 32.75. Support at 27.68.